181 related articles for article (PubMed ID: 31629403)
1. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
BMC Neurol; 2019 Oct; 19(1):241. PubMed ID: 31629403
[TBL] [Abstract][Full Text] [Related]
2. The Relationship between Selected Demographic Factors and Speech Organ Dysfunction in Sporadic ALS Patients.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32764342
[No Abstract] [Full Text] [Related]
3. Oral motor functions, speech and communication before a definitive diagnosis of amyotrophic lateral sclerosis.
Makkonen T; Korpijaakko-Huuhka AM; Ruottinen H; Puhto R; Hollo K; Ylinen A; Palmio J
J Commun Disord; 2016; 61():97-105. PubMed ID: 27110704
[TBL] [Abstract][Full Text] [Related]
4. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
[TBL] [Abstract][Full Text] [Related]
5. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms.
Makkonen T; Ruottinen H; Puhto R; Helminen M; Palmio J
Int J Lang Commun Disord; 2018 Mar; 53(2):385-392. PubMed ID: 29159848
[TBL] [Abstract][Full Text] [Related]
6. Multiple orofacial indices in amyotrophic lateral sclerosis.
DePaul R; Brooks BR
J Speech Hear Res; 1993 Dec; 36(6):1158-67. PubMed ID: 8114482
[TBL] [Abstract][Full Text] [Related]
7. Articulatory Range of Movement in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
Lee J; Bell M
Am J Speech Lang Pathol; 2018 Aug; 27(3):996-1009. PubMed ID: 29800071
[TBL] [Abstract][Full Text] [Related]
8. Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Sobuś A; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Paczkowska E; Rotter I; Nowacki P; Machaliński B
Stem Cells Int; 2019; 2019():7213854. PubMed ID: 31281384
[TBL] [Abstract][Full Text] [Related]
9. Automatic prediction of intelligible speaking rate for individuals with ALS from speech acoustic and articulatory samples.
Wang J; Kothalkar PV; Kim M; Bandini A; Cao B; Yunusova Y; Campbell TF; Heitzman D; Green JR
Int J Speech Lang Pathol; 2018 Nov; 20(6):669-679. PubMed ID: 30409057
[No Abstract] [Full Text] [Related]
10. Automatic extraction of abnormal lip movement features from the alternating motion rate task in amyotrophic lateral sclerosis.
Rong P; Yunusova Y; Richburg B; Green JR
Int J Speech Lang Pathol; 2018 Nov; 20(6):610-623. PubMed ID: 30253671
[No Abstract] [Full Text] [Related]
11. Communicative Participation in People with Amyotrophic Lateral Sclerosis.
Sixt Börjesson M; Hartelius L; Laakso K
Folia Phoniatr Logop; 2021; 73(2):101-108. PubMed ID: 31918429
[TBL] [Abstract][Full Text] [Related]
12. Articulatory Kinematic Characteristics Across the Dysarthria Severity Spectrum in Individuals With Amyotrophic Lateral Sclerosis.
Lee J; Bell M; Simmons Z
Am J Speech Lang Pathol; 2018 Feb; 27(1):258-269. PubMed ID: 29209698
[TBL] [Abstract][Full Text] [Related]
13. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Pius-Sadowska E; Litwińska Z; Kotowski M; Meller A; Rotter I; Peregud-Pogorzelski J; Nowacki P
Int J Med Sci; 2020; 17(13):1927-1935. PubMed ID: 32788871
[No Abstract] [Full Text] [Related]
14. Speaking rate effects on articulatory pattern consistency in talkers with mild ALS.
Mefferd AS; Pattee GL; Green JR
Clin Linguist Phon; 2014 Nov; 28(11):799-811. PubMed ID: 24724615
[TBL] [Abstract][Full Text] [Related]
15. Physiologic deficits in the orofacial system underlying dysarthria in amyotrophic lateral sclerosis.
Langmore SE; Lehman ME
J Speech Hear Res; 1994 Feb; 37(1):28-37. PubMed ID: 8170127
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of patient-report and speech-language pathologists' ratings for detecting the early onset of bulbar symptoms due to ALS.
Allison KM; Yunusova Y; Campbell TF; Wang J; Berry JD; Green JR
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):358-366. PubMed ID: 28355886
[TBL] [Abstract][Full Text] [Related]
17. Speech intelligibility in people with Amyotrophic Lateral Sclerosis (ALS).
Leite Neto L; França Júnior MC; Chun RYS
Codas; 2021; 33(1):e20190214. PubMed ID: 33533830
[TBL] [Abstract][Full Text] [Related]
18. Segmental timing in amyotrophic lateral sclerosis.
Tjaden K; Turner G
J Speech Lang Hear Res; 2000 Jun; 43(3):683-96. PubMed ID: 10877438
[TBL] [Abstract][Full Text] [Related]
19. Predicting Speech Intelligibility Based on Spatial Tongue-Jaw Coupling in Persons With Amyotrophic Lateral Sclerosis: The Impact of Tongue Weakness and Jaw Adaptation.
Rong P; Green JR
J Speech Lang Hear Res; 2019 Aug; 62(8S):3085-3103. PubMed ID: 31465706
[TBL] [Abstract][Full Text] [Related]
20. [The application of dysarthria profile tests in ALS patients for the detection of speech disturbances].
Tomik B; Głodzik-Sobańska L; Lechwacka A; Bała-Słodowska M; Kolasa M; Szczudlik A
Neurol Neurochir Pol; 2000; 34(2):269-79. PubMed ID: 10962720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
